Abstract
We have previously shown with i.v. bolus studies that the elimination of propofol is much slower than previously reported. Now we have studied the implications of this for prolonged i.v. infusion of propofol in seven patients who received continuous infusions of propofol for up to 9 h. Values of elimination half-life ranged from 13.1 to 44.7 h, systemic clearance from 1.02 to 1.63 l h-1 and volume of distribution from 1390 to 3940 l and these were similar to those obtained with bolus administration. The large volume of distribution is consistent with the high octanol/blood partition coefficient, which was found to be 72.0. Despite the very long elimination half-life, blood propofol concentrations appeared to approach steady state within 20 min rather than the 4-5 half-lives normally expected. This is because for this drug, which displays multicompartment pharmacokinetics, the rate of initial rise of blood concentrations is governed primarily by the very short distribution half-life of the drug. Therefore, the long elimination half-life of propofol is probably of little significance in designing infusions regimens, but the lower systemic clearance should be taken into account to avoid unwanted accumulation.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Campbell G. A., Morgan D. J., Kumar K., Crankshaw D. P. Extended blood collection period required to define distribution and elimination kinetics of propofol. Br J Clin Pharmacol. 1988 Aug;26(2):187–190. doi: 10.1111/j.1365-2125.1988.tb03386.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cockshott I. D., Briggs L. P., Douglas E. J., White M. Pharmacokinetics of propofol in female patients. Studies using single bolus injections. Br J Anaesth. 1987 Sep;59(9):1103–1110. doi: 10.1093/bja/59.9.1103. [DOI] [PubMed] [Google Scholar]
- Gelman S. I. Disturbances in hepatic blood flow during anesthesia and surgery. Arch Surg. 1976 Aug;111(8):881–883. doi: 10.1001/archsurg.1976.01360260049012. [DOI] [PubMed] [Google Scholar]
- Gepts E., Camu F., Cockshott I. D., Douglas E. J. Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg. 1987 Dec;66(12):1256–1263. [PubMed] [Google Scholar]
- Kay N. H., Sear J. W., Uppington J., Cockshott I. D., Douglas E. J. Disposition of propofol in patients undergoing surgery. A comparison in men and women. Br J Anaesth. 1986 Oct;58(10):1075–1079. doi: 10.1093/bja/58.10.1075. [DOI] [PubMed] [Google Scholar]
- Plummer G. F. Improved method for the determination of propofol in blood by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1987 Oct 9;421(1):171–176. doi: 10.1016/0378-4347(87)80394-8. [DOI] [PubMed] [Google Scholar]
- Schüttler J., Stoeckel H., Schwilden H. Pharmacokinetic and pharmacodynamic modelling of propofol ('Diprivan') in volunteers and surgical patients. Postgrad Med J. 1985;61 (Suppl 3):53–54. [PubMed] [Google Scholar]
- Servin F., Desmonts J. M., Haberer J. P., Cockshott I. D., Plummer G. F., Farinotti R. Pharmacokinetics and protein binding of propofol in patients with cirrhosis. Anesthesiology. 1988 Dec;69(6):887–891. doi: 10.1097/00000542-198812000-00014. [DOI] [PubMed] [Google Scholar]
- Shafer A., Doze V. A., Shafer S. L., White P. F. Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology. 1988 Sep;69(3):348–356. doi: 10.1097/00000542-198809000-00011. [DOI] [PubMed] [Google Scholar]
- Simons P. J., Cockshott I. D., Douglas E. J., Gordon E. A., Hopkins K., Rowland M. Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol. Xenobiotica. 1988 Apr;18(4):429–440. doi: 10.3109/00498258809041679. [DOI] [PubMed] [Google Scholar]